Valuation: Mega Lifesciences

Market Cap 32.91B 985M 861M 796M 735M 1.38B 94.62B 1.41B 9.49B 3.72B 46.33B 3.7B 3.62B 160B P/E 2026 *
14.2x
P/E 2027 * 13.4x
Enterprise Value 28.3B 847M 740M 684M 632M 1.19B 81.36B 1.21B 8.16B 3.2B 39.84B 3.18B 3.11B 137B EV / Sales 2026 *
1.9x
EV / Sales 2027 * 1.8x
Free-Float
38.61%
Yield 2026 *
4.63%
Yield 2027 * 4.97%
1 day+1.34%
1 week-0.66%
Current month+2.72%
1 month+11.03%
3 months+10.22%
6 months+7.09%
Current year+12.69%
1 week 36.5
Extreme 36.5
37.75
1 month 34
Extreme 34
38
Current year 31.5
Extreme 31.5
40
1 year 26.75
Extreme 26.75
40
3 years 24.3
Extreme 24.3
46.75
5 years 24.3
Extreme 24.3
56.5
10 years 15.9
Extreme 15.9
56.5
Manager TitleAgeSince
Chief Executive Officer 64 31/12/1987
Director of Finance/CFO 61 31/12/1996
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 61 31/12/1997
Director/Board Member 64 31/12/2012
Director/Board Member 73 31/01/2013
Date Insider Type Main position Quantity % Market Cap.
28/04/25Buy

Chief Executive Officer

100,000 0.0115%
27/04/25Buy

Chief Executive Officer

150,000 0.0172%
27/04/25Buy

Chief Executive Officer

50,000 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+1.34%-0.66%+42.45%-1.31% 971M
-2.37%-6.67%+44.26%+156.55% 1,054B
-1.91%-5.52%+61.00%+57.93% 621B
-0.86%-3.71%+28.03%+80.28% 438B
-1.12%-3.68%+26.89%+20.58% 325B
-1.73%-3.45%+26.95%+44.09% 281B
-1.95%-13.92%+15.96%+19.76% 262B
-1.45%-2.37%-27.87%-39.87% 219B
-1.04%-3.28%+19.86%+56.55% 195B
-0.52%-4.31%+16.41%+69.04% 163B
Average -1.20%-1.33%+25.39%+46.36% 355.72B
Weighted average by Cap. -1.73%-1.68%+33.10%+76.99%

Financials

2026 *2027 *
Net sales 14.88B 445M 389M 360M 332M 626M 42.77B 637M 4.29B 1.68B 20.94B 1.67B 1.64B 72.11B 15.61B 467M 408M 377M 349M 657M 44.88B 669M 4.5B 1.77B 21.98B 1.76B 1.72B 75.67B
Net income 2.32B 69.44M 60.68M 56.09M 51.83M 97.6M 6.67B 99.36M 669M 262M 3.27B 261M 255M 11.25B 2.46B 73.62M 64.34M 59.48M 54.95M 103M 7.07B 105M 709M 278M 3.46B 277M 270M 11.92B
Net Debt -4.61B -138M -121M -112M -103M -194M -13.26B -198M -1.33B -522M -6.49B -518M -507M -22.35B -4.76B -142M -124M -115M -106M -200M -13.67B -204M -1.37B -538M -6.7B -535M -523M -23.05B
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
13/07/26 THB 37.75 +1.34% 737,163
13/07/26 THB 37.25 +0.68% 700,210
10/07/26 THB 37.00 -1.33% 702,563
09/07/26 THB 37.50 +1.35% 457,501
08/07/26 THB 37.00 -1.99% 1,334,709
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
37.75THB
Average target price
41.14THB
Spread / Average Target
+8.99%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEGA Stock